MISTR
MISTR is a U.S. direct-to-consumer telemedicine platform providing free online PrEP, long-term HIV care, STI testing, and erectile dysfunction treatment to over 800,000 adults nationwide, funded through the 340B Drug Pricing Program.
- Company typePrivate
- Founded2018
- HeadquartersMiami Beach, United States
- Headcount11–50
- GTM typeB2C
- OfferingSoftware
What MISTR does
MISTR is a direct-to-consumer telemedicine platform that provides free online access to HIV pre-exposure prophylaxis (PrEP), long-term HIV care, erectile dysfunction treatment, and sexually transmitted infection (STI) prevention services including DoxyPEP. The platform serves over 800,000 adults across all 50 U.S. states through a three-step digital workflow: a roughly three-minute online health questionnaire, a virtual consultation with a licensed physician, and at-home or in-person lab testing, culminating in free discreet home delivery of medication. It is described as the nation's largest telehealth platform for HIV prevention, with an Emory University study published in JAMA indicating MISTR serves nearly one in five Americans using PrEP.
The company's technology stack is a self-serve, product-led telehealth platform integrating online consultations, e-prescribing, lab logistics (at-home kits and in-person networks), and nationwide pharmacy fulfillment. Recent product additions include long-acting injectable PrEP, expanding beyond oral Truvada/Descovy regimens, and DoxyPEP for STI post-exposure prophylaxis. MISTR also handles prior authorizations, prescription auto-renewals, insurance premium support (up to $250/month for affected patients), and patient assistance program enrollment. The company maintains strong cultural integration with the LGBTQ+ community through celebrity ambassadors (Kim Petras, Madonna, Dua Lipa), LGBTQ+ nightlife venue activations via Tryst Hospitality (The Abbey, The Chapel in West Hollywood), and a producing partnership with the Broadway musical Titanique.
MISTR operates a freemium business model in which all clinical services — consultations, labs, STI testing, and medication delivery — are provided at zero out-of-pocket cost to patients. Revenue is generated through the 340B Drug Pricing Program, which allows covered entities to purchase drugs at reduced prices and capture the spread between acquisition cost and payer reimbursement; most insurance plans are accepted and uninsured patients are enrolled in manufacturer patient assistance programs. Founded in 2018 and led by CEO Tristan Schukraft, MISTR is a privately held, founder-led company with 11–50 employees and operational ties to both Miami Beach, FL and West Hollywood, CA. No institutional funding rounds, revenue figures, or ownership changes are disclosed in available sources.
MISTR firmographics
Firmographics- Name
- MISTR
- Legal name
- MISTR
- Website
- https://mistr.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MISTR is a U.S. direct-to-consumer telemedicine platform providing free online PrEP, long-term HIV care, STI testing, and erectile dysfunction treatment to over 800,000 adults nationwide, funded through the 340B Drug Pricing Program.
- Ownership category
- akta.pro rank
MISTR industry classification
Industry- Product category
- Telemedicine / HIV Prevention & Sexual Health
- NAICS
- Health Care and Social Assistance (62)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Infectious Disease & STI Testing-to-Treatment with eRx + Pharmacy Fulfillment (HLALAIAL)
Keywords
Where MISTR is headquartered
LocationHeadquarters
- HQ city
- Miami Beach
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
MISTR business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Free telehealth services (340B-funded): MISTR provides free consultations, labs, STI testing, and medication delivery to patients at zero out-of-pocket cost. The company leverages the 340B Drug Pricing Program to fund free care. Most insurance plans are accepted, and uninsured patients can qualify for patient assistance programs. The core service is free to the end user.
- 340B Drug Pricing Program: MISTR generates revenue through the 340B Drug Pricing Program, which allows covered entities to purchase drugs at reduced prices and receive full reimbursement from payers, enabling the delivery of free PrEP and HIV care to patients.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | Free comprehensive telehealth for HIV prevention and care |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
MISTR product offering
Product offeringCore offering
MISTR is a direct-to-consumer online sexual health and telehealth platform that provides free PrEP (Truvada/Descovy), long-acting injectable PrEP, DoxyPEP, STI testing, long-term HIV care, and erectile dysfunction treatment. Patients complete an online health questionnaire, undergo a virtual physician consultation, complete at-home or in-person lab testing, and receive medications shipped discreetly to their door at zero out-of-pocket cost, with services funded through the 340B Drug Pricing Program and patient assistance programs.
Product overview
MISTR is an online sexual health platform offering three core services—PrEP (Pre-Exposure Prophylaxis), Long-Term HIV Care, and Erectile Dysfunction Treatment—alongside supplementary offerings including STI Testing, DoxyPEP, and Long-Acting Injectable PrEP. The platform connects over 800,000 adults with licensed physicians via online consultations, provides free at-home or in-person lab testing, and delivers medications discreetly to patients' doors. MISTR leverages the 340B Drug Pricing Program to fund free PrEP and preventive care. All services are accessible online without office visits, with free delivery anywhere in the United States.
Differentiator
Problem solved
Functional benefit
Products and services
- PrEP (Pre-Exposure Prophylaxis)
- Long-Term HIV Care
- Erectile Dysfunction Treatment
- STI Testing
- DoxyPEP
- Long-Acting Injectable PrEP
Quantifiable outcome
- Nearly 1 in 5 Americans using PrEP receive it through MISTR's telehealth platform (Emory University/JAMA study)
- +3 more outcomes
Companies that use MISTR
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles2 records
MISTR technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
MISTR partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and flagship.
- The Abbey (Tryst Hospitality)coreMISTR co-hosted Madonna's surprise appearance at The Abbey nightclub in West Hollywood on April 29, 2026, celebrating the venue's newly expanded dance floor. The Abbey and its sister space The Chapel are operated by Tristan Schukraft under Tryst Hospitality. MISTR serves as co-host, aligning its brand with LGBTQ+ nightlife culture and reaching a celebrity-heavy audience including Addison Rae, Lily Allen, and Bebe Rexha.
- TitaniqueflagshipMISTR founder Tristan Schukraft joined the producing team of Titanique, a musical playing on Broadway (opened March 26, 2026; run through July 12). MISTR activates around the Broadway run with integrated marketing and content campaigns aimed at driving ticket sales and PrEP awareness. Titanique extends into Tryst Hospitality LGBTQ+ venues. This is a bidirectional partnership combining entertainment, LGBTQ+ culture, and health awareness.
- Kim PetrascoreMISTR partnered with Grammy-winning artist and LGBTQ+ icon Kim Petras, who serves as a brand ambassador throughout 2026. The partnership includes a New Year's Eve event, a major marketing campaign, and ongoing collaborations related to Petras' music and public appearances. Kim Petras represents MISTR's alignment with LGBTQ+ cultural figures to drive awareness and enrollment.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
MISTR competitors and assessment
Company assessmentDirect peers
- Nurx: Telehealth platform offering online PrEP, STI testing, birth control, and other sexual health services. Highly comparable to MISTR on product, target customer, and pharmacy-fulfilled ePrescribing model; now part of Thirty Madison.
- Folx Health: LGBTQ+-focused telehealth platform providing hormone therapy, PrEP, sexual health, and mental health care. Closest direct competitor in the LGBTQ+ telehealth category MISTR anchors.
- Plume: Telehealth platform specializing in gender-affirming care and sexual health for the transgender and LGBTQ+ community. Comparable in mission, demographic focus, and direct-to-consumer virtual care delivery.
- Wisp: Telehealth platform offering sexual and reproductive health services including STI testing, ED treatment, and contraception. Overlaps with MISTR's core offering of online sexual-health consultations and medication delivery.
Broad incumbents
- Hims & Hers Health: Large public telehealth platform offering men's and women's health, including ED, mental health, and primary care. A broader incumbent that overlaps with MISTR on ED and could enter HIV prevention with its marketing and pharmacy scale.
- Ro: Direct-to-patient telehealth platform offering men's sexual health, fertility, weight management, and primary care. Comparable in online consult + medication fulfillment model, with overlapping ED and sexual health offerings.
- Thirty Madison: Multi-brand virtual care platform (including Nurx) treating chronic and everyday conditions. Operates a PrEP/STI brand (Nurx) that competes directly with MISTR and signals the consolidator model in this category.
Emerging players
- TBD Health: Telehealth and at-home testing platform focused on STI screening, PrEP, and sexual wellness. Smaller and earlier-stage but overlaps directly with MISTR's testing-plus-treatment workflow.
- Sesame: Telehealth and online pharmacy marketplace offering direct-pay virtual visits and prescription fulfillment. Comparable online consult + medication delivery model, with broader primary care rather than sexual-health specialization.
Others
- GoodRx: Drug pricing transparency and telehealth platform. Not a direct competitor on PrEP care delivery, but an enabling ecosystem player that intersects with MISTR's medication-access value proposition through pricing and fulfillment.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
MISTR social profiles
Digital presenceMISTR financial estimates
Financial estimateRevenue estimate
Valuation estimate
MISTR leadership team
Management profileNumber of profiles
Profiles1 record
MISTR funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MISTR M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MISTR
What does MISTR do?
MISTR is a direct-to-consumer online sexual health and telehealth platform that provides free PrEP (Truvada/Descovy), long-acting injectable PrEP, DoxyPEP, STI testing, long-term HIV care, and erectile dysfunction treatment. Patients complete an online health questionnaire, undergo a virtual physician consultation, complete at-home or in-person lab testing, and receive medications shipped discreetly to their door at zero out-of-pocket cost, with services funded through the 340B Drug Pricing Program and patient assistance programs.
Is MISTR a public or private company?
MISTR is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was MISTR founded?
MISTR was founded in 2018. It employs 11 to 50 people.
Where is MISTR based?
MISTR is headquartered in Miami Beach, United States, in the North America region.
How does MISTR make money?
Two revenue lines are on record. Free telehealth services (340B-funded) is the primary driver. The others are 340B Drug Pricing Program.
Who are MISTR's main competitors?
Direct peers on record are Nurx, Folx Health, Plume and Wisp. Broad incumbents are Hims & Hers Health, Ro and Thirty Madison. Emerging players are TBD Health and Sesame. GoodRx is listed as an others.
Does MISTR have an API?
No public API is recorded for MISTR.
What industry is MISTR in?
MISTR's product category is Telemedicine / HIV Prevention & Sexual Health. Its primary akta.pro industry code is HLALAIAL, Infectious Disease & STI Testing-to-Treatment with eRx + Pharmacy Fulfillment. Its NAICS code is 62 and its SIC code is 8011.